课题基金 / 基金详情

Studies in Scleroderma and Cystic Fibrosis Osteoporosis

Studies in Scleroderma and Cystic Fibrosis Osteoporosis
硬皮病和囊性纤维化骨质疏松症的研究
批准号:
6511751
负责人:
PETER A MERKEL
金额:
$11.9万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-07-18 至 2006-06-30

项目摘要

项目成果

PETER A MERKEL的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): To provide support for research projects in the field of rheumatology that will form the basis of a structured mentoring program for young investigators pursuing careers in patient-oriented clinical research. This application has two major specific research aims: 1) Develop new outcome measures for skin assessment in scleroderma for use in clinical trials and 2) Determine the prevalence and progression of osteoporosis in patients with cystic fibrosis (CF). Both projects will have direct relevance to furthering the health of the populations under study. Clinical research in scleroderma, including therapeutic trials, is greatly hampered by a lack of reliable and precise outcome measurements of disease activity. Skin thickening and fibrosis are major causes of morbidity and dysfunction for patients with scleroderma. The great success in extending the life expectancy of patients with CF gained in the last 20 years has resulted in patients now experiencing diseases as adults not formerly encountered in this population. Among these diseases is osteoporosis. Patients with CF appear to be at high risk for osteoporosis due to nutritional, pharmacologic, and genetic factors but the pathophysiology and extent of the problem is not known. Patients with scleroderma will be followed prospectively and evaluated for skin disease activity by skin scoring, durometer readings (thickness), light-based technologies, skin biopsies, self-assessments, and functional status instruments. These data will be analyzed to determine a core set of outcome measures for scleroderma. and validated by an expert panel of national researchers in this disease. An observational cohort of patients with CF will be studied. Baseline and 2-year measurements of bone density, nutritional status, and biochemical markers of bone turnover will performed. A comprehensive program for training new clinical investigators by the principal investigator is proposed. This program includes trainees taking an active and integral role in the research studies described. Additionally, trainees will be enrolled in formal coursework in biostatistics, epidemiology, and clinical research techniques leading to a master degree. A unique seminar and a series of support services at the host institution will further complement the training program.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
VASCULITIS CLINICAL RESEARCH NETWORK (VCRN): RARE DISEASE
  • 批准号:
    7167055
  • 项目类别:
  • 资助金额:
    $125.0万
  • 财政年份:
    2005
  • 负责人:
    PETER A MERKEL
  • 依托单位:
GENETIC POLYMORPHISMS IN WEGENER'S GRANULOMATOSIS
  • 批准号:
    7206265
  • 项目类别:
  • 资助金额:
    $0.26万
  • 财政年份:
    2004
  • 负责人:
    PETER A MERKEL
  • 依托单位:
DEVELOPMENT AND VALIDATION OF OUTCOME MEASURES FOR SYSTEMIC SCLEROSIS
  • 批准号:
    7206245
  • 项目类别:
  • 资助金额:
    $0.74万
  • 财政年份:
    2004
  • 负责人:
    PETER A MERKEL
  • 依托单位:
STUDY OF ENBREL IN THE TREATMENT OF WEGENER'S GRANULOMATOSIS
  • 批准号:
    7206313
  • 项目类别:
  • 资助金额:
    $1.25万
  • 财政年份:
    2004
  • 负责人:
    PETER A MERKEL
  • 依托单位:
海外基金